Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: Advancements in Stem Cell-Derived Vascularized Organoids and Optimized Isolation of Wharton's Jelly for Enhanced MSC Production
Published on: July 5, 2024
Umbilical cord milking-benefits and risks
Jenny Koo1, Hasan Kilicdag2, Anup Katheria1
1Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, United States.
Umbilical cord milking (UCM) offers a practical alternative to delayed cord clamping (DCC) for placental blood transfer, especially for newborns needing immediate resuscitation. While UCM is easier to perform, its safety, particularly in preterm infants, requires further investigation.
Area of Science:
- Neonatal Medicine
- Perinatal Care
- Pediatric Physiology
Background:
- Delayed cord clamping (DCC) and umbilical cord milking (UCM) are common methods for placental blood transfer.
- DCC poses risks of hypothermia and delayed resuscitation.
- Umbilical cord milking with resuscitation (UCM-R) and delayed cord clamping with resuscitation (DCC-R) allow immediate resuscitation.
Purpose of the Study:
- To review the benefits and risks of umbilical cord milking (UCM).
- To explore the safety profile of UCM, especially in preterm neonates.
- To assess UCM as a practical option for non-vigorous and preterm infants.
Main Methods:
- Literature review of studies on DCC, UCM, and DCC-R.
- Analysis of safety and efficacy data for UCM in various neonatal populations.
- Exploration of ongoing research regarding UCM.
Main Results:
- UCM is considered easier to perform than DCC-R.
- UCM is a potential option for non-vigorous term/near-term and preterm neonates needing respiratory support.
- The safety of UCM, particularly in preterm infants, is still a concern.
Conclusions:
- UCM presents a viable alternative to DCC, offering easier implementation and immediate resuscitation capabilities.
- Further research is crucial to fully establish the safety and efficacy of UCM, especially in vulnerable preterm populations.
- UCM is being considered for widespread adoption, pending further safety data.
More Related Videos
07:26Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
Published on: January 26, 2019
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023